PIN1 and cancer: Moreover, cinobufacini injection (CI), an aqueous extract of Cutis bufonis, has been demonstrated to dose-dependently inhibit Pin1 enzyme activity, resulting in the impaired expression of Pin1 both in vitro and in vivo, and is used clinically in cancer therapy in China (73).